N
Google TrendJONAS BROTHERS (500+) — Jonas Brothers postpone Birmingham concert over weather concerns
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:jonas brothers500+steven kwan500+kings vs warriors200+steffi graf200+boxing200+ben simmons500+lisa500+bill maher500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "International myeloma wor" (30 stories)

Top Headline Story

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma
Lead StoryNatureworld
Mar 25

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5zcG5uYV9KM1NNQ0JQUnVoZmdFT01xWC1nVXRjUGVlc0pEMDBzZFBzZVNkYlpKWTh3NEg1ZUcyWXRwcXdWR01IT1JqOG9MeElLSW9QWkU5QWoyUGFMR2xr?oc=5" target="_blank">Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+15m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

Filter stories
500+15m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

Filter stories
200+15m ago

kings vs warriors

3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings

Filter stories
200+15m ago

steffi graf

PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance

Filter stories

Search Results for "International myeloma wor"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Real-World Tolerability of Cilta-Cel Aligns With Multiple Myeloma Trials
Targeted Oncologyworld

Real-World Tolerability of Cilta-Cel Aligns With Multiple Myeloma Trials

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZ0RxZ083YXpxVlBHeU5YblVhd1RxNDFlOE5nd1lxZ2I1LWRBdjNmRkpSc1c0MGRGM3gtNHpmUXNHQW5Zd3hhbmstT0tqck0ybm9jbmVlVGpyREhZWFdXVG9ZcEU3Y2hfbUVtWEpSek14RUVmT1A2UUcxalZ2ZWlma1UwbmsyUFZadnk2U09JRXE2NU1aeFFWZXAwZDVab3dldjk4S1Q5Y20?oc=5" target="_blank">Real-World Tolerability of Cilta-Cel Aligns With Multiple Myeloma Trials</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Legend Biotech to Present Updated Long-Term and Real-World
GlobeNewswiretech

Legend Biotech to Present Updated Long-Term and Real-World

<a href="https://news.google.com/rss/articles/CBMixAJBVV95cUxNRkd2X0xYZWlPTnNoUjBpcUpNSUJYcUc1YnpjNjFwX2hxTUNhYU4zUVZMaGRmWllyaW9SMVZxbUxhdW1BcU1URlhnWndtSzEyWF9wZzVyZmt4eHctdHduMjFQOHdMM3oyR29lOHRPTHJUZEsxZjg1TDRydmJ2UEllaWQ1MTBnSlItbUJNNk9xOHI2bGNyTEFueU8xX0s1RjRaOHktS0Q1Y2R0QzlRRDI4bEpPYVhGN1U2aG1GQjZ0NjM4SmVnOHdERTgtQW1rM2RPWU13QmIwMF9va1Nmek5EN3g1cy1GOW9kWGVSNzFjbUJtNVZmYUE5RVEyb1QyQWxhY3Q3cG0xVUJ4LVAzb08xM2FhamNkYzEyT1huSmJ5QkxPUm0tT3BFQnBnb1h5Vl82SFdVYlQyYVN0QUdiTmF0UTJtcVA?oc=5" target="_blank">Legend Biotech to Present Updated Long-Term and Real-World</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
Protein degrader approval offers hope to relapsed multiple myeloma patients
Chemistry Worldgeneral

Protein degrader approval offers hope to relapsed multiple myeloma patients

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNb0szbTI4alVJT2Z3NEZDeVNhUDZMNnRHUXh4NjRQazlqVHAwdzBZaERTMEZScFhyN3dBT0pBT3JmV1VUSjZhU2NJVG9jRmxUYVJmRlBFUkNQbWFxRWo3MXlvOEVFVHhYTEhyT3BqbVJTWHdKNDRPaF9UWl9WUW10N3J3TWNONHAwSEhzYTBOaFZVLXc3eEhkNVRPdmMtcGowOGtxMTZLUUhvNGhQYkx4T0lrNDBpZi1vNXN2dUgwVGN2MW1UN0E?oc=5" target="_blank">Protein degrader approval offers hope to relapsed multiple myeloma patients</a>  <font color="#6f6f6f">Chemistry World</font>

Read Full StoryMore like this
Multiple Myeloma: Improved Prognosis With the Latest Treatments
Memorial Sloan Kettering Cancer Centergeneral

Multiple Myeloma: Improved Prognosis With the Latest Treatments

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQdG9MbGhQYlhFZ1Q1VGhtUE5Sc2YyaEtZREJ2YzdIWG4yS2pHcEN4M1kta1FUd2lPTUhCeUVueUZrM083YXNvQ0w3ZFN5bU1OQ3JOM19JbWlfMndEa0lhNERhNXhjTHk0LXB2WFJKSHpQUEV3MjJLM2xfWG5CMlNBTTBYUUlJNVE?oc=5" target="_blank">Multiple Myeloma: Improved Prognosis With the Latest Treatments</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Read Full StoryMore like this
Dr Biran on the Real-World Performance of SKY92 Gene Expression Profiling for Risk Stratification in Multiple Myeloma
OncLiveworld

Dr Biran on the Real-World Performance of SKY92 Gene Expression Profiling for Risk Stratification in Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQZlNyb2tCbWlLZFlUMHlSLUx2WDVpTDdFUTNNWnZlWWNlWTRROHRDSGFqbVFjR3Z6MlBnVjNmSlZSd1Z3NzhHOEV5Z3YteE5sZ1BQN0JoYWFNbXpRS0pvazdfZmxDbzZLdlNDWlFXRVFsM1NQOHYyemdHME9ZXzNFc3RwX1RyYllxSTNlTDM5QlFoc0dWMk5rQTlLeFhUTGlnektQendzUE9xanUwemV1Rmg0WDFNWmh6eFhfOXBpOVB0XzAtN2RnVW9tclNTdWx0ZWY1WEFQaXNwdERCeDhZ?oc=5" target="_blank">Dr Biran on the Real-World Performance of SKY92 Gene Expression Profiling for Risk Stratification in Multiple Myeloma</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry
Oncodailyworld

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE5LTkprRGhfRlNpR1BJMy10TVZweFhmXzZmSS11alZGcF9rNHhBdEFKNW00TGRwX29BUThDNDM4Mk9HcUl4MWJxeVRGVkRpOU45YTJuSVVDb3hHaGVsQjF6TWlVUXptNnJnRWp2LW42RjhjTFhhUUR5QmpUTW1EUQ?oc=5" target="_blank">Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
Andrew Portuguese, MD, on Multiple Myeloma: Real-World Outcomes With Elranatamab
The ASCO Postworld

Andrew Portuguese, MD, on Multiple Myeloma: Real-World Outcomes With Elranatamab

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOb011cURwb3AzZ0g1QUExUmNYcDhkNXliWEZZZWptMDk3QjRteEU1QUszbDNWLTNyQkN5VWEzaW1KdXVQVGpIT2xpb21ZM0tIY1c2QWJ0cmF6eWZXZVJPV2RFV2dZN3ZpOExXOEIwZjk0bnNnNGEtTnZTeXhxQl9Ta3NhVWZMakVqX0l4Sl9NVndpNW9yVVE?oc=5" target="_blank">Andrew Portuguese, MD, on Multiple Myeloma: Real-World Outcomes With Elranatamab</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma
CancerNetworktech

Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQTHBsa3E0QjlvNkl6MHU3eHc4ZWpQOTRQZVVucXpndmtkS2EwYUtGaTN2UGVhNnRRNWRUOUpwb3dtX1NPWmRiMHZhdHlJaWprVTN6cjVZdGpZcFV0NnNkWWIxamhZaHJZeGNDSl81YlZpOTJIaER6SUxTOENRcVJWdlFlS09ZRWxxYW84QkNzS0NOLXFEVVNCU0dzaDU3cDJ5VkJmZktEeVc0bVNVM2FON08xVGUwUQ?oc=5" target="_blank">Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma
Cure Todaygeneral

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQWk4wUmtwM1gtUFFKOTVBRGtkeVpBYzI3eFNMMTh4blJCUmJIVmY4N1lRbi1sOTNuV0FndUFvRzZJLVJOa3l1dmVKM2xlZHhrRE11T3UzOC1YcHVYTGJjaXdidmhUdFo2a0x0TzZBcnZoQW9XUkJMT0hnazdOQ1QzSHYydFdDZG41ejNITDVQRzB0OWdqdXJWdUVUMTdsQUVBYVI4?oc=5" target="_blank">How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal
Natureworld

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yNktMcld5Y2ljeFg0WU1EVXVOdk9FUERsVDlpVTBfQ3JQY0tESEFYZkhIYjVyMGtKdlNKRk5PSVU3b2ZYc3kxN2xSZldzRUZOUWhYNVlEckE4dlEwOFQw?oc=5" target="_blank">Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Pharmacists Weigh Real-World Challenges of Bispecific Antibodies in Multiple Myeloma
Pharmacy Timesworld

Pharmacists Weigh Real-World Challenges of Bispecific Antibodies in Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQWEwzZGJxS2toRWI4Yk94RklVLXJVd294dEtRd1hOSFMzYjA5VHhPbDhkd014TE5Odk13UzZieHJGSGdFcEJrU3RVaHYyVVBmdlJnYVFsck0zRlNsQVVTVVJ5RFlpR1hzZTRvMVYtQml5RnhVTEFzd1VNbEx2OWZXZnFxVERlXzlqVUY4YnhMRWhmRGd5TmdNT2d4amFUQnNYVG9Ybno5QkZIZ2hKMmxOQlUtR2JaWXhqZDIw?oc=5" target="_blank">Pharmacists Weigh Real-World Challenges of Bispecific Antibodies in Multiple Myeloma</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Examining Real-World Approaches for GPRC5D Bispecific in Multiple Myeloma
Targeted Oncologyworld

Examining Real-World Approaches for GPRC5D Bispecific in Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOMmotRnJHLWw3d1FLeUZjUDVRbHlmeFlTdDlRYzJpNUxvNEV4NlFWRHUxVHIyUUxYREhka3h0TTBTMzIxN1kzbmU2aGtYSTNYZW9FQ1BoZFR0QWEtQTBYdDN3cGJaSFY2MzFKVnprWFN2cWphWGhBZWZIYXhqSFlROFJLNEM2SnZZSzZYNkh0U1BqYlh6ekhtMUlqWWRxNGNZTkltb1ptNkJXQQ?oc=5" target="_blank">Examining Real-World Approaches for GPRC5D Bispecific in Multiple Myeloma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Balancing Clinical Trial and Real-World Evidence in Multiple Myeloma
OncLiveworld

Balancing Clinical Trial and Real-World Evidence in Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNM2pmd2ZsUGdiY1JLWV9JQlAtTUs5NHltSXYyNkhrcGxuUERnSFhxZWQ0eHlSZ0ozcXZyME5pTm8tWDZLTVNRODNzTms0NE5rY2hGREVYMTRpWEVwSndOb0FlN0tVLUZJVlcxWkIwNnJib2s3WWhKRlFMZ0Jlb2tsRElfTk5TcVVJSkdCX2tfZEpyYmdvQThZb2MxTUVFZw?oc=5" target="_blank">Balancing Clinical Trial and Real-World Evidence in Multiple Myeloma</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108
Natureworld

Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE12Zy1SWkREeGNDb25WQlpfMlZjTW9ocHUyVklaemNxSHB4QWhtSmhlSHJsOENtZDRhcEVoTWJ2SGlqaGVWcFJ3NUx4THZBZm9SUF9YN3dYQzduVzh0a1lz?oc=5" target="_blank">Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States
Natureworld

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE10c3lGVGZfdVFXNVI0bGhwZW9XVkxVVldSakxncEFXcjk1Z0JXb283MDdnVDYzdG9NZEM1dkpWOU4tWXB5amtEVFk4MklhNGJla2JFQXZsSllnWFYzU19z?oc=5" target="_blank">Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry
Natureworld

Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2TG0tS3ZILUtwZXAxSnF2NG95MldEMDdyUnU2TUdXNmJvejBZeGpWdm1QcWp3WmRua2puRy15TzZNRHBncDM4cGIxdlpaQW9GVDJtT2pkZGtTbWFZSXhZ?oc=5" target="_blank">Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)—real world experience from the US multiple myeloma immunotherapy consortium |
Natureworld

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)—real world experience from the US multiple myeloma immunotherapy consortium |

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB3d2FLT0NXQnh0cUNEVFdnaEo5cnQ2c3ZjUTNQMmtfUnhDQ3oycW9hOHVNMHlUUmowMVVYUGRvZWV6cnMyS3NzcEVCM0UyQ0tuMmF3NkxFU3Q2MmJyWmRJ?oc=5" target="_blank">Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)—real world experience from the US multiple myeloma immunotherapy consortium |</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience | Blood Cancer Journal
Natureworld

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA3MzNqeV80enZnNDY5QXczckY5SEJoOWZwYXdLbUNraGtXQ3Bscy1tbVFYMUg2Z05xYkljNWt6MkpfaUxPcmRRbHdPVzVja2lHRVY3cDNabG5vRUwzVFdZ?oc=5" target="_blank">The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Utilization of real-world evidence in regulatory approvals for multiple myeloma therapies | Blood Cancer Journal
Natureworld

Utilization of real-world evidence in regulatory approvals for multiple myeloma therapies | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TTm5hN2loQmlLQU5GRU5ncTZZMWJEcXVTVFRKNlRoTElUNGVPU2R6LTJyTHN0YlUtNWQyRi1ITlZpT0dHY2s4aFk1RUVuc2U0XzFRZUVUWk1HUEIxR2FB?oc=5" target="_blank">Utilization of real-world evidence in regulatory approvals for multiple myeloma therapies | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Evaluating Clinical Trial Data and Real-World Evidence of Bispecific Antibodies in Multiple Myeloma
AJMCworld

Evaluating Clinical Trial Data and Real-World Evidence of Bispecific Antibodies in Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOek1NR2VhdkFBSnhXWnRaSFhqX2tCYkRaTllrT2pBdlpCSk5McW5fQWZYWjI4cG9ial9aNERNLW5UR3JiTUxQUUdXWjlBYzVkRWFKXzRLRWxicHU5NkpNRENuN29mSjlHZDhHY3RWaHJlS0JLdHprbDVSUFZLcG1GN2l0Vm9Tb2NaTTI1SlRpWFo0a3dmWVcxTURlUFJLWEdYbFNFcWV5TmFVWlpGQ0hHWHphYXVkUmhXMVhHMU1qNERNVWs?oc=5" target="_blank">Evaluating Clinical Trial Data and Real-World Evidence of Bispecific Antibodies in Multiple Myeloma</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
Real-World Multiple Myeloma Outcomes Across Treatment Lines
European Medical Journalworld

Real-World Multiple Myeloma Outcomes Across Treatment Lines

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNRUgySXJ5VHhuc0E4RVpYZ3JVWTEzOWdXRlItVS1jNUJ1ci16WTc1U29feTUzNWlYZEZGZHJ1Z3ljbk1HcDdKdXlRSlFFMi1GUHVJNFMwOVFCR0dwd1lEWW5WbmQ4VFRtTFBRZlBLcER2OXNKUHFYQ2N4YTZIek1DakJSeGNIUUFiNW9JN3hTT1ZWalRHQjYzdG5xQnRpSHBMOHo4?oc=5" target="_blank">Real-World Multiple Myeloma Outcomes Across Treatment Lines</a>  <font color="#6f6f6f">European Medical Journal</font>

Read Full StoryMore like this
Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study
Natureworld

Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE02MHBfdy1QRlZnWHIzR25aQVZ4QXA1bVJ1Y0FXeDFqc2VUQmxRdUs4M01zcXBmczFFS09HeU1KOHM3VHBsNWkzZ3NJUzJsSXphWE5mN0FuaGhVZWhHM3pF?oc=5" target="_blank">Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Optical Genome Mapping for Cytogenetic Analysis in Multiple Myeloma: Real-World Evidence
Wiley Online Libraryworld

Optical Genome Mapping for Cytogenetic Analysis in Multiple Myeloma: Real-World Evidence

<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTFA0ejJLTk9xcVVSMnJla0Ruc3BmTXhLT01MTllSRjRSa3pwdlVBQ0xRZWN3UUZMT0JNdmFTMUNiX0Rib1F5NUloX0xOMVppRl9RRGRMUHFTSjJCbkVtajFhWHJIZw?oc=5" target="_blank">Optical Genome Mapping for Cytogenetic Analysis in Multiple Myeloma: Real-World Evidence</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal
Natureworld

Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE41ZkRRWkVQV2EtbjNhbWs4SzNsRXd5VE1ycG5qT1I0akpldV8wejJXdm0zb2gxTG5EUF9zSFVWYjFpT0FVOG5FcVlBNDEzQjg4UDVPMVFTakxtaUM1SWdz?oc=5" target="_blank">Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study
Natureworld

Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83MjZyYzJZbG9FWjNUeGwwUEE5ZjItRnFadEN0Mk13Z2tLQzg1ZGxmWk9aVzdLUzdwU2hZTjNwTk95NkkwYWtOZl81YmpWLS1LUEptLTBEOXl0emdjOXVR?oc=5" target="_blank">Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Longest survival in the world reported to date for multiple myeloma patients
News-Medicalworld

Longest survival in the world reported to date for multiple myeloma patients

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOMDZjU0V6TUZsNS1rYkZYOXEtY0ROWHN0cEgyNnpGUjFrN1l4dS15c01GN2ZrbmI3OTFKVkJFRWZtdkt2NHI3bGgtSndfcDVPN2hpRDJKTXNjRHpxR2NkZ2haSkRudFd2N3Qtd1VneFhBVy1Wd3RUbkhBdF95bG9vN0dFV1NpWFNIS3B4dG1fcUt3YU1xdVBjUmVab0hSTWFsVXFkLVVZb1R4WllFbFRwWFVMUFFDaUdaVHc5ei02a25aUQ?oc=5" target="_blank">Longest survival in the world reported to date for multiple myeloma patients</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study | Blood Cancer Journal
Natureworld

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0tSE5xcjlEYXJUR2JYRFpBZmFxN1l5VHFGNTkwTXlLRnhzSGZILWkzbWw0Uk1YY0lOYzFUNGZFcXZKWEdoZ0JKZlk2UDJ0T2c4dXZSYVZmTWF6cHIwUGZJ?oc=5" target="_blank">Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma | Leukemia
Natureworld

International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma | Leukemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9CNnBjRkE5UDBlYzF4anpwclZlVmp5MVQ4Nm5STWh2ZlZfNGlfZTQ1UE9FeFVHR2ZRV0VkNEwzRGxBRkgxLVNDN05LbUZ5c0c1MUpWdjFGRnFjSkZ4SllN?oc=5" target="_blank">International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma | Leukemia</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
TB and multiple myeloma groups say they’ll light up legislature
Cabin Radiogeneral

TB and multiple myeloma groups say they’ll light up legislature

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQzc0OUtIMC12bk41YmZENmRHWGYwUHFyZTRtdTlmU05vaHdaenlxVV9qVXlvYm1mdG9PR0xVMUEwSV9ZbUM0WnJ0NXJQdHFzZjRucDNZQmdCREhCcTFaVUN1czZxQ1J1aktNaXc1NHIzd095ajhRME1HSXVraWh6MGpYZGk3OVhKSEFybjI1S3BmWVJQX1BmcjQwVmJaT1pxc1U4Z3JiYkJFZw?oc=5" target="_blank">TB and multiple myeloma groups say they’ll light up legislature</a>  <font color="#6f6f6f">Cabin Radio</font>

Read Full StoryMore like this
"International myeloma wor" — Live Google News Trends & Headlines